Literature DB >> 9539339

Late components of the event-related potentials and their topography in Parkinson's disease.

J Lagopoulos1, P Clouston, H Barhamali, E Gordon, W M Li, J Lesley, J G Morris.   

Abstract

Late components of the event-related potential (ERP; N100, P200, N200, and P300) were elicited using an auditory oddball paradigm (with a button-press response to target stimuli) in 15 Parkinson's disease (PD) patients and 50 normal control subjects. Compared with control subjects, PD subjects showed a significant decrease in N200 amplitude. Between-group topographical differences in N200 amplitude were evident at central (C3, Cz, C4) and temporal (T5, T3, T4, T6) regions. The results may reflect a deficit in response selection in PD possibly resulting from a dysfunction associated with the abnormalities in the central and temporal regions found to have a decreased N200 amplitude compared with normal control subjects in this study.

Entities:  

Mesh:

Year:  1998        PMID: 9539339     DOI: 10.1002/mds.870130211

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

1.  Objective assessment of cognitive factors involved in visceral perception by using event-related cerebral evoked responses to esophageal target stimulation in man.

Authors:  S Hollerbach; A May; M V Kamath; G Shine; A R Upton; G Tougas
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

2.  Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects.

Authors:  Andres H Neuhaus; Terry E Goldberg; Youssef Hassoun; John A Bates; Katharine W Nassauer; Serge Sevy; Carolin Opgen-Rhein; Anil K Malhotra
Journal:  Schizophr Res       Date:  2009-04-07       Impact factor: 4.939

3.  Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study.

Authors:  Perrine Bocquillon; Jean-Louis Bourriez; Ernesto Palmero-Soler; Luc Defebvre; Philippe Derambure; Kathy Dujardin
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.